41 results
F-1
EX-10.7
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
matter, right, obligation, determination or election which is the responsibility of or which is allocated to the Company herein, provided such person … HEREUNDER. THE COMPANY DOES NOT ASSUME ANY RESPONSIBILITY TO ADVISE THE GRANTEE ON SUCH MATTERS, WHICH SHALL REMAIN SOLELY THE RESPONSIBILITY
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
, or the TCJA, included a provision that repealed, effective January 1, 2019, the tax-based shared responsibility payment imposed by the ACA on certain … for international operations. The U.S. Department of Justice and the SEC, which have responsibility for enforcement of the FCPA, both consider employees
6-K
EX-10.1
SPRC
SciSparc Ltd
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as management of the Company believes
6-K
EX-4.1
SPRC
SciSparc Ltd
28 Nov 23
Report of Foreign Private Issuer
4:01pm
are and shall be deemed to have been made by the Company only.
(e) The Rights Agent shall not be under any responsibility in respect of the validity
6-K
EX-10.1
yggzocaly02q
12 Oct 23
SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
8:48am
6-K
EX-1.1
66yibe2e
14 Aug 23
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
4:31pm
6-K
EX-99.1
dgz6dv2px1d64gb
16 May 23
At-The-Market Issuance Sales Agreement
8:06pm
6-K
EX-10.3
dc6i dxhi3a55myb2bw
4 Apr 23
SciSparc completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million
7:07am
6-K
EX-99.3
l1maek k1uc
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
6-K
EX-99.1
dvzq6yjwqdavc
11 Aug 22
Current Report
4:05pm
6-K
EX-99.2
jsllhmq
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
EX-99.2
vc8galt24ts 5fhy7by
2 Mar 21
Report of Foreign Private Issuer
4:05pm
6-K
EX-1.1
bx1wmrmwx6s a5k3t9
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
6-K
EX-4.1
0d40xd6hhcbksy60s
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
F-1/A
EX-1.1
g75t61gyy9
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
EX-4.6
a82 nb57op5tmw
4 Nov 20
Registration statement (foreign) (amended)
2:14pm